French Society of Anaesthesia and Intensive Care (SFAR : Société Française d'Anesthésie Réanimation)
Guidelines on Preventing Medication Errors in Anaesthesia and Intensive Care
Ce document comprend 29 recommandations.
Contenu en anglais
Synthèse
These professional practice guidelines were co-developed by the French Society of Anaesthesia and Intensive Care (SFAR) and the French Society of Clinical Pharmacy (SFPC). Based on an extensive 20-year literature search analyzed using the GRADE method, a panel of 19 French experts established 29 recommendations across four core fields: work environment and processes, human and organizational factors, post-hoc risk management, and drug shortages.
Medication errors are critical risks in anesthesia and intensive care settings. To provide actionable guidance despite a sparse number of highly-powered studies addressing direct medication error outcomes, SFAR and SFPC collaborated to draft Professional Practice Guidelines rather than Formalized Expert Recommendations, utilizing GRADE methodology to reach strong expert consensus.
Messages clés
The French Society of Anaesthesia and Intensive Care (SFAR) and the French Society of Clinical Pharmacy (SFPC) partnered to develop professional practice recommendations for preventing medication errors [1].
A panel of 19 French experts formulated clinical questions using the PICO model and conducted a 20-year bibliographic search aligned with PRISMA guidelines [1, 2].
Because few studies had sufficient power to directly measure medication error outcomes, the experts chose to publish Professional Practice Guidelines (PPG) rather than Formalized Expert Recommendations [2].
The guideline covers four domains: (1) Work environment and processes; (2) Human and organizational factors; (3) Post-hoc risk management; and (4) The problem of drug shortages [2].
The development process resulted in 29 recommendations evaluated via the GRADE grid method, achieving strong agreement across all items among the expert panel [2, 3].
















